The global Eubiotics market was valued at USD 5.82 billion in 2023 and is anticipated to reach USD 6.29 billion in 2024 from USD 11.75 billion by 2032, growing at a CAGR of 8.12% from 2024 to 2032.
The eubiotics market is showcasing evident potential in the mentioned forecasting period. Eubiotics play a vital role in providing medicinal benefits to livestock, such as preclusion and preventing other diseases common in animals. Apart from this, they also carry nutritional value with them. The increase in the capability of producing eubiotics and commercialization of farming has led agriculture-based industries to take interest in the market lately. Eubiotics are generally used as feed additives for animals. They help prevent various diseases in animals, thus keeping them healthy and, in turn, increasing their productivity. It creates an appropriate balance of the microflora in our gastrointestinal tract and helps in maintaining a hygienic living.
The ban on antibiotics has created an open window for eubiotics to enter the agriculture industry and take their place. It has been one of the major reasons for the recent growth of the eubiotics market. Other important factors driving the global eubiotics market growth include the industrialization of the livestock industry, rising demand for naturally derived products, and increasing instances of livestock disease.
These factors have been responsible for the growth of the market lately, although some of the factors have resulted in being hurdles to the eubiotics market as well. Some of them are competition for raw materials from other industries, regulatory framework, and low awareness of product efficiency.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024 to 2032 |
|
CAGR |
8.12% |
|
Segments Covered |
Based on type, Based on Livestock |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Addcon, Royal DSM, BASF SE, CHR. Hansen A/S, Kemin Industries Inc., Cargill Incorporated, E. I. Du Pont De Nemours and Company, Novus International Inc., Behn Meyer Group, Beneo Group. |
Probiotics are further fragmented in lactobacilli, bifidobacteria, and others. Prebiotics are segmented into inulin, fructooligosaccharides, galactooligosaccharides, and others. Probiotics lead the market share under type segmentation because of their efficiency over other types. The eubiotics market for poultry is expected to have the highest CAGR among all the sub-segments of livestock, as Eubiotics help increase the growth rate of poultry and maintain their high nutritional value.
Eubiotics market was dominated by Europe. Europe was followed by Asia-Pacific and North America. The Asia Pacific is predicted to grow at a rapid pace in the coming few years with the help of investments from several multinational manufacturers.
Some of the major companies dominating the eubiotics market through their products and services include Addcon, Royal DSM, BASF SE, and CHR. Hansen A/S, Kemin Industries Inc., Cargill Incorporated, E. I. Du Pont De Nemours and Company, Novus International Inc., Behn Meyer Group and Beneo Group.
By Type
By Livestock
By Region
Frequently Asked Questions
The eubiotics market is expected to grow at a CAGR of 8.12% to reach USD 10471.71 million by 2029.
Global Eubiotics Market was expected to be valued at USD 6555.13 million in 2023.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region